Agency Information Collection Activities: Proposed Collection; Comments Requested, 48943-48944 [E6-13908]
Download as PDF
Federal Register / Vol. 71, No. 162 / Tuesday, August 22, 2006 / Notices
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Patrick Henry
Building, Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: August 17, 2006.
Lynn Bryant,
Department Clearance Officer, Department of
Justice.
[FR Doc. E6–13907 Filed 8–21–06; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0033]
Agency Information Collection
Activities: Proposed collection;
Comments Requested:
Drug Enforcement
Administration, DOJ.
ACTION: 60-Day Notice of Information
Collection Under Review: Report of
Mail Order Transaction.
cprice-sewell on PROD1PC66 with NOTICES
AGENCY:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted for
‘‘sixty days’’ until October 23, 2006.
This process is conducted in accordance
with 5 CFR 1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, Washington, DC 20537.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
VerDate Aug<31>2005
15:34 Aug 21, 2006
Jkt 208001
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of this information
collection:
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Report of Mail Order Transaction.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: none. Office
of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: None.
Abstract: The Comprehensive
Methamphetamine Control Act of 1996
(Pub. L. 104–237) (MCA) amended the
Controlled Substances Act to require
that each regulated person who engages
in a transaction with a non-regulated
person which involves ephedrine,
pseudoephedrine, or
phenylpropanolamine (including drug
products containing these chemicals)
and uses or attempts to use the Postal
Service or any private or commercial
carrier shall, on a monthly basis, submit
a report of each such transaction
conducted during the previous month to
the Attorney General.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that there are
twenty-four (24) total respondents for
this information collection. Fourteen
(14) responded on paper at 1 hour for
each response and ten (10) responded at
15 minutes per form, for an annual
burden of 168 hours for paper forms and
30 hours for electronic forms.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
198 annual burden hours associated
with this collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
48943
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: August 17, 2006.
Lynn Bryant,
Department Clearance Officer, Department of
Justice.
[FR Doc. E6–13906 Filed 8–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0029]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
Drug Enforcement
Administration, DOJ.
ACTION: 60-Day Notice of Information
Collection Under Review: Annual
Reporting Requirement for
Manufacturers of Listed Chemicals.
AGENCY:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted for
‘‘sixty days’’ until October 23, 2006.
This process is conducted in accordance
with 5 CFR 1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, Washington, DC 20537.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
E:\FR\FM\22AUN1.SGM
22AUN1
48944
Federal Register / Vol. 71, No. 162 / Tuesday, August 22, 2006 / Notices
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
cprice-sewell on PROD1PC66 with NOTICES
Overview of This Information
Collection:
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Annual Reporting Requirement for
Manufacturers of Listed Chemicals.
(3) Agency form number, if any and
the applicable component of the
Department sponsoring the collection:
Form number: none. Office of Diversion
Control, Drug Enforcement
Administration, U.S. Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: None. Abstract: This
information collection permits the Drug
Enforcement Administration to monitor
the volume and availability of
domestically manufactured listed
chemicals. These listed chemicals may
be subject to diversion for the illicit
production of controlled substances.
This information collection is required
by law.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that there are
one hundred (100) total respondents for
this information collection. One
hundred (100) persons respond
annually at 4 hours per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
400 annual burden hours associated
with this collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: August 17, 2006.
Lynn Bryant,
Department Clearance Officer, U.S.
Department of Justice.
[FR Doc. E6–13908 Filed 8–21–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
15:34 Aug 21, 2006
Jkt 208001
DEPARTMENT OF JUSTICE
Drug
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on May 8, 2006,
Aldrich Chemical Company Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
OH 45342–4304, made application by
renewal, to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedule I and II:
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
Gamma
hydroxybutyric
acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid dethylamide (7315)
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4-Methylenedioxy-methamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol Except LevoAlphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ...................
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Merperidine intermediate-B (9233)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Morphine (9300) ...........................
Normorphine (9313) .....................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug testing and analysis.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, VA 22301; and must be
filed no later than October 23, 2006.
Dated: August 15, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–13849 Filed 8–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 25, 2006,
American Radiolabeled Chemicals, Inc.,
101 Arc Drive, St. Louis, Missouri
63146, made application by renewal,
and by correspondence dated June 2,
2006, to the Drug Enforcement
Administration (DEA) for registration as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
E:\FR\FM\22AUN1.SGM
22AUN1
Agencies
[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Pages 48943-48944]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13908]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0029]
Agency Information Collection Activities: Proposed Collection;
Comments Requested
AGENCY: Drug Enforcement Administration, DOJ.
ACTION: 60-Day Notice of Information Collection Under Review: Annual
Reporting Requirement for Manufacturers of Listed Chemicals.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA), has submitted the following information collection request to
the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. Comments are encouraged and will be accepted for
``sixty days'' until October 23, 2006. This process is conducted in
accordance with 5 CFR 1320.10.
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Mark W. Caverly, Chief, Liaison and Policy
Section, Office of Diversion Control, Drug Enforcement Administration,
Washington, DC 20537.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
[[Page 48944]]
--Enhance the quality, utility, and clarity of the information to be
collected; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection:
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Annual Reporting Requirement for
Manufacturers of Listed Chemicals.
(3) Agency form number, if any and the applicable component of the
Department sponsoring the collection: Form number: none. Office of
Diversion Control, Drug Enforcement Administration, U.S. Department of
Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Business or other for-profit. Other:
None. Abstract: This information collection permits the Drug
Enforcement Administration to monitor the volume and availability of
domestically manufactured listed chemicals. These listed chemicals may
be subject to diversion for the illicit production of controlled
substances. This information collection is required by law.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: It is estimated
that there are one hundred (100) total respondents for this information
collection. One hundred (100) persons respond annually at 4 hours per
response.
(6) An estimate of the total public burden (in hours) associated
with the collection: It is estimated that there are 400 annual burden
hours associated with this collection.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: August 17, 2006.
Lynn Bryant,
Department Clearance Officer, U.S. Department of Justice.
[FR Doc. E6-13908 Filed 8-21-06; 8:45 am]
BILLING CODE 4410-09-P